Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center

This study was designed to assess prognostic factors associated with relapse-free survival (RFS) after neoadjuvant chemotherapy (NAC) for breast cancer.A single-institution retrospective analysis was performed including clinical, radiographic, and pathologic parameters for all breast cancer patients treated with NAC from 2015 to 2018. All patients had pre-and post-NAC MRI.For 102 patients, median follow-up was 47.4 months, and the five-year RFS...